Tag: NBPP

Stakeholder Perspectives on CMS’s 2023 Notice of Benefit and Payment Parameters: State Insurance Departments and Marketplaces

Posted by

After the Biden administration issued the proposed 2023 “Notice of Benefit and Payment Parameters,” several hundred stakeholders provided feedback on the new set of rules governing the ACA’s marketplaces and health insurance standards. To better understand the impact of the proposed rules, CHIR reviewed a sample of stakeholder comments. For the third blog in our series, Rachel Schwab summarizes comments submitted by state departments of insurance and state-based marketplaces.

Stakeholder Perspectives on CMS’s 2023 Notice of Benefit and Payment Parameters: Insurers and Brokers

Posted by

The Biden administration has proposed significant changes to the Affordable Care Act’s health insurance marketplaces through the annual “Notice of Benefit & Payment Parameters.” In this second of a three-part series, CHIR’s Megan Houston and Sabrina Corlette review the comments and recommendations that participating health insurers have submitted in response.

Stakeholder Perspectives on CMS’s 2023 Notice of Benefit and Payment Parameters: Consumer Advocates

Posted by

In the recently released 2023 “Notice of Benefit & Payment Parameters,” the Biden administration is proposing significant changes to the Affordable Care Act marketplaces. In the first of a three-part series, CHIR’s Emma Walsh-Alker and JoAnn Volk reviewed public comments from multiple consumer advocacy organizations about the impact of the new policies on marketplace beneficiaries. Reviews of comments from insurers and state marketplaces and insurance departments will follow.

Stakeholder Perspectives on Round Three of CMS’s 2022 Notice of Benefit and Payment Parameters. Part 3: Consumer Advocates

Posted by

The Biden administration has proposed several policy changes designed to boost enrollment in the Affordable Care Act marketplaces. In the third post of a 3-part blog series, JoAnn Volk and Nia Gooding review comments submitted by several consumer and patient advocacy groups. Prior posts reviewed comments from health insurers and state marketplace and insurance officials.

Stakeholder Perspectives on Round Three of CMS’s 2022 Notice of Benefit and Payment Parameters. Part 2: Insurers

Posted by

In the newly proposed 2022 “Notice of Benefit & Payment Parameters” the Biden Administration is reversing course on a number of policies that impact the ACA marketplaces. In the second of a three-part series, CHIR’s Megan Houston reviewed public comments from insurers about the proposed rule. Reviews of comments from consumer organizations will follow.

Stakeholder Perspectives on Round Three of CMS’s 2022 Notice of Benefit and Payment Parameters. Part 1: State Insurance Departments and Marketplaces

Posted by

The Biden administration is signaling significant changes for the Affordable Care Act marketplaces with its proposed 2022 “Notice of Benefit & Payment Parameters.” In the first of a three-part series, CHIR’s Rachel Schwab and Rachel Swindle reviewed public comments from state insurance departments and marketplaces about the impact of the new policies. Reviews of comments from insurers and consumer organizations will follow.

Stakeholder Perspectives on CMS’s 2022 Notice of Benefit and Payment Parameters. Part 2: State Insurance Departments and Marketplaces

Posted by

In one of the Trump administration’s last acts, the Centers for Medicare and Medicaid Services finalized some of the major provisions of the 2022 Notice of Benefit and Payment Parameters. In the second part of our blog series reviewing stakeholder comments, CHIR’s Rachel Schwab takes a look at how state insurance departments and state-based marketplaces responded to some of the recently finalized proposals.

The Final 2021 Notice of Benefit and Payment Parameters: Implications for States

Posted by

The Trump administration has released the annual rule governing insurance standards and marketplace operations under the Affordable Care Act. In an Expert Perspective for the Robert Wood Johnson Foundation’s State Health & Value Strategies project, Sabrina Corlette assesses the implications for state insurance regulation and the state-based marketplaces.

The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.